Ocera Therapeutics, Inc. Retained Earnings
Ocera Therapeutics, Inc. had Retained Earnings of -$177.41 million as of 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2017-11-14
- 2017-09-30: Retained Earnings (Accumulated Deficit) -$177.41M.
- 2017-06-30: Retained Earnings (Accumulated Deficit) -$171.14M.
- 2017-03-31: Retained Earnings (Accumulated Deficit) -$165.01M.
- 2016-12-31: Retained Earnings (Accumulated Deficit) -$158.33M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2017-09-30 | -$177.41M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$171.14M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | -$165.01M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | -$158.33M 10-Q · filed 2017-11-14 | |
| 2016-09-30 | -$153.18M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | -$146.05M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | -$138.95M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | -$131.43M 10-K · filed 2017-03-14 | |
| 2015-09-30 | -$124.36M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$117.78M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | -$111.56M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$104.91M 10-K · filed 2016-03-11 | |
| 2014-09-30 | -$99.38M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | -$92.77M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | -$85.55M 10-Q · filed 2014-05-13 | |
| 2013-12-31 | -$81.49M 10-K · filed 2015-03-13 | |
| 2013-09-30 | -$74.19M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$135.34M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$132.87M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | -$63.97M 10-K · filed 2014-03-18 | -$129.47M 10-K · filed 2013-03-28 |
| 2012-09-30 | -$124.61M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | -$120.66M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | -$115.05M 10-Q · filed 2012-05-11 | |
| 2011-12-31 | -$106.63M 10-K · filed 2013-03-28 | |
| 2011-09-30 | -$98.61M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | -$92.19M 10-Q · filed 2011-08-11 | |
| 2010-12-31 | -$84.42M 10-K · filed 2012-02-29 |